Literature DB >> 16626789

Abnormally sialylated fibrinogen gamma-chains in a patient with chronic thromboembolic pulmonary hypertension.

Timothy A Morris1, James J Marsh, Peter G Chiles, Nick H Kim, Kyle J Noskovack, Marisa M Magana, Ralph A Gruppo, Virgil L Woods.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16626789     DOI： 10.1016/j.thromres.2006.02.010

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  7 in total

1.  Carbohydrate-binding activities of coagulation factors fibrinogen and fibrin.

Authors:  Kimie Date; Mami Ohyama; Haruko Ogawa
Journal:  Glycoconj J       Date:  2015-06-07       Impact factor: 2.916

2.  High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension.

Authors:  Timothy A Morris; James J Marsh; Peter G Chiles; Marisa M Magaña; Ni-Cheng Liang; Xavier Soler; Daniel J Desantis; Debby Ngo; Virgil L Woods
Journal:  Blood       Date:  2009-05-06       Impact factor: 22.113

3.  Chronic exposure to fibrin and fibrinogen differentially regulates intracellular Ca2+ in human pulmonary arterial smooth muscle and endothelial cells.

Authors:  Amy L Firth; Jocelyn Yau; Amanda White; Peter G Chiles; James J Marsh; Timothy A Morris; Jason X-J Yuan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-04-10       Impact factor: 5.464

4.  Platelets in pulmonary hypertension: a causative role or a simple association?

Authors:  Keyhan Sayadpour Zanjani
Journal:  Iran J Pediatr       Date:  2012-06       Impact factor: 0.364

5.  Fibrinogen and the prediction of residual obstruction manifested after pulmonary embolism treatment.

Authors:  Benjamin Planquette; Olivier Sanchez; James J Marsh; Peter G Chiles; Joseph Emmerich; Grégoire Le Gal; Guy Meyer; Tanya Wolfson; Anthony C Gamst; Roger E Moore; Gabriel B Gugiu; Timothy A Morris
Journal:  Eur Respir J       Date:  2018-11-15       Impact factor: 33.795

6.  Fibrinogen Aα Thr312Ala polymorphism specifically contributes to chronic thromboembolic pulmonary hypertension by increasing fibrin resistance.

Authors:  Ji-Feng Li; Yuan Lin; Yuan-Hua Yang; Hui-Li Gan; Yan Liang; Jie Liu; Su-Qiao Yang; Wei-Juan Zhang; Na Cui; Lan Zhao; Zhen-Guo Zhai; Jun Wang; Chen Wang
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240

7.  Fibrin structure in organized thrombotic material removed during pulmonary artery endarterectormy: the effect of vessel calibre.

Authors:  Piotr Mazur; Bogusław Gawęda; Joanna Natorska; Michał Ząbczyk; Anetta Undas; Jerzy Sadowski; Grzegorz Kopeć; Marcin Waligóra; Piotr Podolec; Bogusław Kapelak
Journal:  J Thromb Thrombolysis       Date:  2016-08       Impact factor: 2.300
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.